Viewing Study NCT01366092


Ignite Creation Date: 2025-12-24 @ 3:50 PM
Ignite Modification Date: 2026-01-01 @ 9:19 AM
Study NCT ID: NCT01366092
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-11
First Post: 2011-06-02
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Daily IL-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease
Sponsor: Dana-Farber Cancer Institute
Organization: